Zobrazeno 1 - 10
of 84
pro vyhledávání: '"Debra, Wujcik"'
Publikováno v:
Bioengineering, Vol 11, Iss 8, p 846 (2024)
Treatment for breast cancer (BC) can lead to debilitating symptoms that can reduce outcomes and quality of life (QoL). Symptom surveillance using a remote symptom monitoring (RSM) platform enables the capture and reporting of patient-reported outcome
Externí odkaz:
https://doaj.org/article/41378120b0214267868195f59ef2e5b7
Publikováno v:
Value in Health. 25:931-936
Remote patient monitoring became critical for patients receiving cancer treatment during the COVID-19 pandemic. We sought to test feasibility of an electronic patient symptom management program implemented during a pandemic. We collected and analyzed
Autor:
Brittany A. McKelvey, Alexandra Berk, Lynda Chin, Stacie Hudgens, Ian Kudel, Ronan C. O'Hagan, Amila Patel, Julie Scott, Hillary Stires, Sam Wang, Debra Wujcik, Mark Stewart, Jeff Allen
Publikováno v:
JCO Clinical Cancer Informatics.
PURPOSE Using patient-reported outcomes (PROs) provides important insights from the patient's perspective and can be valuable to monitor and manage treatment-related adverse events during cancer treatment. Additionally, the digital administration of
Autor:
Jeannine Brant, PhD, APRN, AOCN, FAAN, Debra Wujcik, PhD, RN, FAAN, William N. Dudley, PhD, Alison Petok, MSW, LSW, Brooke Worster, MD, Diane Jones, MSN, NP, Kim Bosket, RN, BSN, OCN, Christian Brady, MSN, AGNP, APRN, Carrie Tompkins Stricker, PhD, RN, ANP-BC
Publikováno v:
Journal of the advanced practitioner in oncology. 13(1)
Background: Pain is a significant problem in patients with cancer. Breakthrough cancer pain contributes to the pain experience, but it is often underassessed and underrecognized. Shared decision-making (SDM), where patient preferences, goals, and con
Autor:
Debra Wujcik, Sandra E. Kurtin, Agnes Davis, Tanya M. Wildes, Carrie Tompkins Stricker, William N. Dudley, Kristy Birchard, Nitya Nathwani, Supriya G. Mohile, Donna Catamero, Brea Lipe
Publikováno v:
JCO Oncology Practice. 16:e92-e99
PURPOSE: Geriatric assessment (GA) results predict toxicity/survival in older adults, yet GA is not routinely used in care for patients with multiple myeloma (MM). We tested a tablet-based modified GA (mGA) providing real-time results to clinicians.
Autor:
Lakedia Charman Banks, Kris Kapphahn, Millie Das, Debra Wujcik, Carrie Tompkins Stricker, Lucinda Shanbhag, Stephanie Lin, Ge Zhu, Manali I. Patel
Publikováno v:
Journal of Clinical Oncology. 40:1520-1520
1520 Background: Improving lung cancer care among Veterans is a priority within the Veterans Affairs due to higher rates of lung cancer incidence, morbidity, and mortality among Veterans compared to non-veterans. Unaddressed symptom burden is common
Autor:
Susie Owenby, Debra Wujcik, Ya-Ning Chan, Ashley Leak Bryant, Matthew C. Foster, Jaime Richardson
Publikováno v:
Journal of the Advanced Practitioner in Oncology
Acute myeloid leukemia (AML) is a disease of older adults, with a median age at diagnosis of 68 years. The availability of oral anticancer medications has increased, although the standard treatment for AML remains in intravenous form. We aim to ident
Autor:
Debra Wujcik, V Keeler, Laura DiGiovanni, Carrie Tompkins Stricker, A Davis, M Gary, P Parsons, X Zhong, LK Han, Scott A. Rush
Publikováno v:
Cancer Research. 78:P4-11
Background: Recent studies show that treating aggressive subtypes of breast cancer (BC) with neoadjuvant chemotherapy (NAC) improves clinical outcomes in addition to breast conservation therapy (BCT) rates. Yet a large multi-site population-level ana
Autor:
Julie M Scott, D'Ambra Dent, Matthew W. Dudley, Gayathri Ravi, Debra Wujcik, Kelly N. Godby, William N. Dudley, Smith Giri, Stacey A. Ingram, Luciano J. Costa, Susan Bal
Publikováno v:
Blood. 138:5019-5019
Background: Over two thirds of patients with Multiple Myeloma (MM) are ≥ 65 years old at the time of diagnosis. Older adults are at greater risk for treatment related toxicity and inferior survival; such risks are inadequately explained by chronolo
Autor:
Stacey A. Ingram, Debra Wujcik, Omer Jamy, Julie M Scott, Matthew W. Dudley, William N. Dudley, D'Ambra Dent
Publikováno v:
Blood. 138:4050-4050
Background: Acute Myeloid Leukemia (AML) is a disease of older adults, with a median age of 68 years at diagnosis. The NCCN guidelines recommend comprehensive geriatric assessments (GA) be included in clinical practice to guide treatment decisions. U